Locations:

Ob/Gyn & Women’s Health

April 23, 2024/Ob/Gyn & Women’s Health/Obstetrics

Pregnancy and the Penicillin-Allergic Patient

Comparing strategies for cesarean prophylaxis with penicillin allergy

April 16, 2024/Cancer

Watching Out for Primary Ovarian Insufficiency

An underdiagnosed condition in patients with cancer

March 15, 2024/Pediatrics/Primary Care

Breastfeeding Duration in U.S. Closely Linked With Length of Maternity Leave

Systemic change needed to improve health outcomes for parents and children, say researchers

March 4, 2024/Ob/Gyn & Women’s Health/Fertility

Fertility Preservation for Patients with Endometriosis

Counseling and careful surgical considerations are key

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

February 14, 2024/Ob/Gyn & Women’s Health/Research

Neighborhood Factors Affect Early Pregnancy Metabolic Health

Deprivation is linked to impaired glucose intolerance and racial disparities

23-WHI-4424673—OGI—CQD—obesity-in-pregnancy-650-450px

January 15, 2024/Ob/Gyn & Women’s Health/Maternal-Fetal Medicine

Adjunctive Azithromycin in Obese Patients Undergoing Unscheduled C-Sections

Perioperative prophylaxis and class III obesity

January 3, 2024/Cancer

Innovative, Collaborative Care for Preserving Fertility

Options expand for patients with cancer and other conditions

23-CNR-4384100-CQD-650×450 Dr Halle Moore

December 8, 2023/Cancer/Research

Fertility and Pregnancy in Young Patients with Breast Cancer

San Antonio Breast Cancer Symposium presentations underscore safety of assisted reproductive technology and pregnancy in women during and after breast cancer treatment

December 8, 2023/Leadership/Executive Education

‘Look to Understand Rather Than To Be Understood’ (Podcast)

Leadership pearls from Margaret McKenzie, MD, hospital vice president

23-WHI-4386458 – OGI – CQD – topical treatment for VIN

November 30, 2023/Ob/Gyn & Women’s Health/Research

Trial Shows Promise for Topical Treatment for VIN

Artesunate ointment is safe well and tolerated patients with vulvar intraepithelial neoplasia

BackPage 2 of 48Next